Join
Live feed
·
INSIDERFilingvia Quantisnow
Aptose Biosciences Inc. logo

Chair, President & CEO Rice William G. bought $20,000 worth of shares (100,000 units at $0.20), increasing direct ownership by 19% to 613,252 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APTO· Aptose Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APTO (Aptose Biosciences Inc.) and more on Quantisnow.